Medical
Intraoperative Radiotherapy
  • Intraoperative Radiotherapy Intraoperative Radiotherapy
  • Intraoperative Radiotherapy Intraoperative Radiotherapy
  • Intraoperative Radiotherapy Intraoperative Radiotherapy
  • Intraoperative Radiotherapy Intraoperative Radiotherapy
  • Intraoperative Radiotherapy Intraoperative Radiotherapy

Intraoperative Radiotherapy

Xstrahl provides UK healthcare professionals and their patients the ability to treat with Intraoperative Radiotherapy (IORT) through the supply of Xoft Axxent systems and ORL (Oncotherapy Resources Ltd) mobile managed service.

The below drop down menus showcase the options that are available through Xstrahl for IORT, as indicated this includes Xoft, which Xstrahl are sole distributors of the Xoft Axxent system in the UK.  Oncotherapy Resources Ltd (ORL) also provide IORT through a mobile managed radiotherapy service, breast cancer patients have benefited from ORL’s SD-IORT in several hospitals throughout the UK.

Contact us
Xoft Axxent System

Xstrahl are sole distributors of the Xoft Axxent system in the UK. Xoft® System is a simple-to-use, portable IORT device, which utilises a disposable miniature x-ray tube (50kV). Minimal radiation shielding is required, avoiding the need to adjust operating theatres and enabling medical personnel to remain with the patient during treatment. More than 2,000 breast cancer patients globally have already been treated with the Xoft® Axxent System.

 

Advantages of the Xoft Axxent System

  • Delivers therapeutic dose directly to the cancerous site
  • No radioisotope regulatory, handling and safety issues
  • Lower shielding requirements brings brachytherapy treatment "out of the bunker"
  • Because of the unique characteristics of the Axxent eBx System, medical personnel may remain in the room
  • Unlike radioactive isotopes, less radiation is delivered to surrounding healthy organs and tissue*
  • Unique design allows for multiple applications

 

Xoft® Electronic Brachytherapy System® Animation

 

 

For more information click on the "Contact Us" above or visit www.xoftinc.com 

 

*Dickler, et al. "A Dosimetric comparison of MammoSite high dose rate brachytherapy and Xoft Axxent electronic brachytherapy," Brachytherapy (6) 2007, 164-168. "A Dosimetric comparison of Xoft Axxent Electronic Brachytherapy and Ir-192 HDR brachytherapy in the treatment of endometrial cancer," Brachytherapy (7) 2008, 154.

Oncotherapy Resources Ltd

SD-IORT enables hospitals to offer patients ‘one dose, one treatment, one day’ radiotherapy option for early breast cancer employing cutting-edge technology, without the need for capital equipment purchase, maintenance costs or service charges, and at a low fee per patient (fully reimbursed by major insurers).

In the UK, breast cancer patients have benefited from ORL’s SD-IORT in several hospitals including Spire, Nuffield Health and BMI. ORL’s single dose radiotherapy treatment is expertly delivered at the point of surgery, offering patients a convenient and effective treatment experience. ORL utilises the Xoft® Axxent Electronic Brachytherapy System to deliver SD-IORT. The system is a simple-to-use, portable treatment device. Because the Xoft® Axxent System is mobile and requires minimal shielding, it can be used in local or regional hospitals, providing access to cutting-edge radiotherapy for breast cancer patients anywhere in the UK.

 

What is included in the service?

  • Delivery, QA, safety checks, set up and removal of machine
  • An ORL operator on site to plan and deliver SD-IORT
  • IR(ME)R regulations fully met
  • Xoft certified surgeon mentoring included (1st patient)
  • All consumables and spares provided
  • Lead screens and dosimeters supplied
  • RPA (radiation protection advisor) approval and advice
  • Fees charged on a per patient treated basis

 

For more information click on the "Contact Us" button below or visit www.oncotherapyresources.com